Monday, June 20, 2016
- 12:30pm-2:00pm
-
Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease
Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study
Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Mortality after deep brain stimulation surgery for patients with advanced Parkinson’s disease
Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Motivators and barriers to participation in exercise in Parkinson’s disease
Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living
Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Motor features and response to levodopa in Parkinson’s disease with normal olfactory function
Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Motor rigidity selectively associates with impaired odor identification in Parkinson’s disease
Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Motor symptoms in patients with early stages of Parkinson’s disease
Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects
Epidemiology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 53
- Next Page»